St. Jude Medical Inc. announced that five-year results from the FAME trial have confirmed the long-term benefits of fractional flow reserve (FFR) in guiding percutaneous coronary intervention (PCI) over angiography alone.

September 9, 2015 — The U.S. Food and Drug Administration (FDA) granted 510(k) for Philips Healthcare’s Spectral Diagnostic Suite (SpDS), which offers a set of advanced visualization and analysis tools designed for the IQon Spectral computed tomography (CT) technology. The software offers enhanced spectral viewing and clinical applications capabilities.

St. Jude Medical Inc. announced primary results from the LEADLESS II study that confirm the positive benefits of the Nanostim leadless pacemaker for patients in need of a single-chamber ventricular pacemaker.

SRI International and DataSpeaks Inc. announced that SRI has licensed the Science of Individuality Measurement Algorithm (SIMA) software from DataSpeaks. SRI will integrate SIMA into the development of a secure enterprise system for clinical decision-making.

Sunshine Heart Inc. announced the U.S. Food and Drug Administration (FDA) has approved an amendment to the stopping rule criteria for the company's COUNTER HF pivotal study for its C-Pulse Heart Assist System. The agency has agreed to change this protocol from "all cause" deaths to specifically, mortality associated with device, procedure or therapy.

In a new study reported in The Journal of Thoracic and Cardiovascular Surgery, researchers found a dramatic difference in cardiac function recovery with extracorporeal life support (ECLS) after cardiogenic shock depending on the nature of the attack. The results underscore the importance of mechanical circulatory support in helping the patient survive.

Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting “should be considered” in patients at low risk for bleeding, investigators for the OPTIDUAL trial recommend.

uberization of healthcare. Physicians are starting to "prescribe" smartphone apps to patients for education, tracking their health or to interface with wearable monitor devices. This physician is using an app created by the American College of Cardiology (ACC) to educate a patient about cardiac function.
New patient portals allow patients immediate access to their health records, including labs,reports and imaging. This is a requirement under Stage 3 Meaningful Use to enable patients to be more involved in their care and to easily share their information with various physicians. 
AliveCor enables a single-lead ECG recordings on a smartphone that can be immediately shared with physician, or scanned by an app to determine if there is an abnormality. These types of devices serve as a basis for mobile healthcare on demand.
The PulsePoint app enables trained CPR responders to get community wide alerts when a 911 center receives a call for sudden cardiac arrest (SCA). The app shows potential first responders near the location on a map of where the patient is located in hopes that they might start CPR prior to the arrival of paramedics. This is an effort to improve CPR response times and SCA survival rates. Pulsepoint, uberization of healthcare, sudden cardiac arrest

Today, in a world of immediate access to information anywhere on the planet using a smartphone, consumers expect more from healthcare, which many experts say will cause a major consumer-driven transformation in care delivery models. Technology has evolved to enable what many are calling the “Uberization” of healthcare, where patients will have instant access to healthcare, similar to the Uber app allowing instant access and online tracking for taxi services.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now